|
|
| MRD / Regn No. |
: SG004592 |
Date |
: 18/06/2026 |
| Patient Name |
: Shruti Ganguly |
Age & Gender |
: 50 Yrs. / Female |
| Contact No. |
: 9733089280 |
UHID |
: |
| Ht / Wt / BMI |
: 162 / 81 / 30.86 |
BP S / BP D |
: 112 / 83 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (18/Jun/2011) | HYPERTENSION (18/Jun/2026) | DYSLIPIDEMIA (18/Jun/2026) | |
| Salient Investigations |
: |
TGL TRIGLYCERIDE: 395 mg/dL | CREATININE: 0.41 | EGFR EGLOMERULAR FILTRATION RATE: 175.77 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 345 mg/dL | HB HEMOGLOBIN: 12.8 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 13.8 % | LDL LOW DENSITY LIPOPROTEIN: 70 mg/dL | MICROALBUMIN CREATININE RATIO: 133.26 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 480 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET CILNIDIPINE (10MG) + TELMISARTAN (40MG)
CETANIL T 40 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
|
|
|
2 |
TABLET ROSUVASTATIN 20 MG
STATEZE R 20 |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
3 |
INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
0-0-22 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
4 |
SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
5 |
ANTIHYPERGLYCEMIC GLIMIPERIDE 2 MG + METFORMIN 500 MG
GEMER 2 MG |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
6 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 18/Dec/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE |
| |
|
| |
|
